CELL INTELLIGENCE · 肿瘤细胞治疗研究

下一代基于抗体的癌症治疗：抗体-药物偶联物和双特异性抗体在血液系统恶性肿瘤和实体瘤中的应用

Next-generation antibody-based therapeutics in cancer: antibody-drug conjugates bispecific antibodies across hematologic malignancies and solid tumors

用于乳腺癌治疗的可注射水凝胶：从肿瘤微环境响应性与主动靶向药物递送到免疫治疗与诊疗一体化

Injectable Hydrogels for Breast Cancer Therapy: From Tumor Microenvironment-Responsive and Actively Targeted Drug Delivery to Immunotherapy and Theran

CAR-T 细胞治疗乳腺癌的进展与挑战：从分子设计到临床应用

Advances and challenges in CAR-T cell therapy for breast cancer: from molecular design to clinical application.

嵌合抗原受体自然杀伤（CAR-NK）细胞治疗乳腺癌的疗效与安全性评价：系统综述与荟萃分析

Evaluation of Efficacy and Safety of Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cells in Breast Cancer: A Systematic Review and Meta-Analysis.

肿瘤相关 Tn 和 STn 抗原：从分子机制到精准诊断与治疗

Tumor-associated Tn and STn antigens: from molecular mechanism to precision diagnosis and treatment.

Tn/STn 抗原在肿瘤发生和免疫逃逸中发挥关键作用，在诊断和治疗方面具有巨大潜力。未来研究应集中于阐明其潜在机制、开发创新检测技术，并促进多学科合作，以推动基于 Tn/STn 抗原的肿瘤分子分型、精准靶向治疗和疗效预测系统的发展，从而为癌症诊断和治疗提供新方向。

嵌合抗原受体 NK 细胞用于乳腺癌免疫治疗

Chimeric antigen receptor NK cells for breast cancer immunotherapy.

整合传统生物标志物与新兴预测因子评估乳腺癌新辅助化疗疗效：Ki-67、CDK4、EGFR、TILs 和 ctDNA 的多因素分析

Integrating traditional biomarkers and emerging predictors to assess neoadjuvant chemotherapy efficacy in breast cancer: a multifactorial analysis of

TNM 分类、EGFR、Ki-67、CDK4 表达、BC 亚型和 NACT 结果对 BC 患者的 pCR 具有预测价值。

调控肿瘤微环境的 CaCO3 基胶体体微反应器可普遍增强肿瘤免疫治疗

Tumor Microenvironment Modulating CaCO(3) -Based Colloidosomal Microreactors Can Generally Reinforce Cancer Immunotherapy.

嵌合抗原受体修饰 T 细胞治疗转移性乳腺癌的研究进展

Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer.

异质性乳腺癌的靶向治疗与免疫治疗

Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer.